These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38375690)

  • 21. The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death.
    Freitas P; Ferreira AM; Arteaga-Fernández E; de Oliveira Antunes M; Mesquita J; Abecasis J; Marques H; Saraiva C; Matos DN; Rodrigues R; Cardim N; Mady C; Rochitte CE
    J Cardiovasc Magn Reson; 2019 Aug; 21(1):50. PubMed ID: 31412875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scar extent as a predictive factor of ventricular tachycardia cycle length after myocardial infarction: implications for implantable cardioverter-defibrillator programming optimization.
    Alexandre J; Saloux E; Lebon A; Dugué AE; Lemaitre A; Roule V; Labombarda F; Champ-Rigot L; Gomes S; Pellissier A; Scanu P; Milliez P
    Europace; 2014 Feb; 16(2):220-6. PubMed ID: 24186956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular magnetic resonance determinants of ventricular arrhythmic events after myocardial infarction.
    Jáuregui B; Soto-Iglesias D; Penela D; Acosta J; Fernández-Armenta J; Linhart M; Ordóñez A; San Antonio R; Terés C; Chauca A; Carreño JM; Scherer C; Falasconi G; Prat-González S; Perea RJ; Mont L; Bosch X; Ortiz-Pérez JT; Berruezo A
    Europace; 2022 Jul; 24(6):938-947. PubMed ID: 34849726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting arrhythmia recurrence following catheter ablation for ventricular tachycardia using late gadolinium enhancement magnetic resonance imaging: Implications of varying scar ranges.
    Bhagirath P; Campos FO; Costa CM; Wilde AAM; Prassl AJ; Neic A; Plank G; Rinaldi CA; Götte MJW; Bishop MJ
    Heart Rhythm; 2022 Oct; 19(10):1604-1610. PubMed ID: 35644355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced myocardial septal function assessed by cardiac magnetic resonance feature tracking in patients with hypertrophic obstructive cardiomyopathy: associated with histological myocardial fibrosis and ventricular arrhythmias.
    Song Y; Bi X; Chen L; Yang K; Chen X; Dong Z; Wang J; Kong X; Zhao K; Wang H; Duru F; Lu M; Ma L; Qiao S; Zhao S
    Eur Heart J Cardiovasc Imaging; 2022 Jul; 23(8):1006-1015. PubMed ID: 35167663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial scar detected by contrast-enhanced cardiac magnetic resonance imaging is associated with ventricular tachycardia in hypertrophic cardiomyopathy patients.
    Suk T; Edwards C; Hart H; Christiansen JP
    Heart Lung Circ; 2008 Oct; 17(5):370-4. PubMed ID: 18562248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ventricular scar channel entrances identified by new wideband cardiac magnetic resonance sequence to guide ventricular tachycardia ablation in patients with cardiac defibrillators.
    Roca-Luque I; Van Breukelen A; Alarcon F; Garre P; Tolosana JM; Borras R; Sanchez P; Zaraket F; Doltra A; Ortiz-Perez JT; Prat-Gonzalez S; Perea RJ; Guasch E; Arbelo E; Berruezo A; Sitges M; Brugada J; Mont L
    Europace; 2020 Apr; 22(4):598-606. PubMed ID: 32101605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-Dimensional Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Predicts Inducibility of Ventricular Tachycardia in Adults With Repaired Tetralogy of Fallot.
    Ghonim S; Ernst S; Keegan J; Giannakidis A; Spadotto V; Voges I; Smith GC; Boutsikou M; Montanaro C; Wong T; Ho SY; McCarthy KP; Shore DF; Dimopoulos K; Uebing A; Swan L; Li W; Pennell DJ; Gatzoulis MA; Babu-Narayan SV
    Circ Arrhythm Electrophysiol; 2020 Nov; 13(11):e008321. PubMed ID: 33022183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated Cardiomyopathy.
    Mueller KA; Heck C; Heinzmann D; Schwille J; Klingel K; Kandolf R; Kramer U; Gramlich M; Geisler T; Gawaz MP; Schreieck J; Seizer P
    PLoS One; 2016; 11(12):e0167616. PubMed ID: 27930686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-risk imaging characteristics in left ventricular apex for the life-threatening arrhythmic events in Japanese hypertrophic cardiomyopathy patients.
    Hen Y; Otaki Y; Iguchi N; Takara A; Takada K; Kanisawa M; Machida H; Inoue K; Takamisawa I; Takayama M
    Heart Vessels; 2023 Dec; 38(12):1442-1450. PubMed ID: 37587371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.
    Moravsky G; Ofek E; Rakowski H; Butany J; Williams L; Ralph-Edwards A; Wintersperger BJ; Crean A
    JACC Cardiovasc Imaging; 2013 May; 6(5):587-96. PubMed ID: 23582356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of cardiac magnetic resonance septal late gadolinium enhancement patterns for periaortic ventricular tachycardia ablation: Heterogeneity of the anteroseptal substrate in nonischemic cardiomyopathy.
    Nishimura T; Patel HN; Wang S; Upadhyay GA; Smith HL; Ozcan C; Shatz DY; Nayak HM; Patel AR; Tung R
    Heart Rhythm; 2021 Apr; 18(4):579-588. PubMed ID: 33301979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ventricular arrhythmias in patients with bicuspid aortic valves.
    Ghannam M; Kovacs B; Liang J; Attili A; Cochet H; Latchamsetty R; Jongnarangsin K; Morady F; Bogun F
    J Cardiovasc Electrophysiol; 2024 Jun; 35(6):1069-1077. PubMed ID: 38509335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy.
    Shiozaki AA; Senra T; Arteaga E; Martinelli Filho M; Pita CG; Ávila LF; Parga Filho JR; Mady C; Kalil-Filho R; Bluemke DA; Rochitte CE
    J Cardiovasc Comput Tomogr; 2013; 7(3):173-81. PubMed ID: 23849490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventive substrate ablation in chronic post-myocardial infarction patients with high-risk scar characteristics for ventricular arrhythmias: rationale and design of PREVENT-VT study.
    Falasconi G; Penela D; Soto-Iglesias D; Francia P; Teres C; Viveros D; Bellido A; Alderete J; Meca-Santamaria J; Franco P; Ordoñez A; Díaz-Escofet M; Matiello M; Maldonado G; Scherer C; Huguet M; Cámara Ó; Ortiz-Pérez JT; Martí-Almor J; Berruezo A
    J Interv Card Electrophysiol; 2023 Jan; 66(1):39-47. PubMed ID: 36227461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.
    Prinz C; Schwarz M; Ilic I; Laser KT; Lehmann R; Prinz EM; Bitter T; Vogt J; van Buuren F; Bogunovic N; Horstkotte D; Faber L
    Can J Cardiol; 2013 Mar; 29(3):358-63. PubMed ID: 22749647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
    Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value of Myocardial Scar Heterogeneity in Hypertrophic Cardiomyopathy.
    Fahmy AS; Rowin EJ; Jaafar N; Chan RH; Rodriguez J; Nakamori S; Ngo LH; Pradella S; Zocchi C; Olivotto I; Manning WJ; Maron M; Nezafat R
    JACC Cardiovasc Imaging; 2024 Jan; 17(1):16-27. PubMed ID: 37354155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of late gadolinium enhancement on cardiac magnetic resonance imaging in ventricular fibrillation and nonischemic cardiomyopathy.
    Voskoboinik A; Wong MCG; Elliott JK; Costello BT; Prabhu S; Mariani JA; Kalman JM; Kistler PM; Taylor AJ; Morton JB
    Pacing Clin Electrophysiol; 2018 Sep; 41(9):1109-1115. PubMed ID: 29931686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-Ablation cardiac Magnetic resonance to assess Ventricular Tachycardia recurrence (PAM-VT study).
    Roca-Luque I; Vázquez-Calvo S; Garre P; Ortiz-Perez JT; Prat-Gonzalez S; Sanchez-Somonte P; Ferro E; Quinto L; Alarcón F; Althoff T; Perea RJ; Figueras I Ventura RM; Guasch E; Tolosana JM; Lorenzatti D; Morr-Verenzuela CI; Porta-Sanchez A; Arbelo E; Sitges M; Brugada J; Mont L
    Eur Heart J Cardiovasc Imaging; 2024 Jan; 25(2):188-198. PubMed ID: 37819047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.